Agomelatine

阿戈美拉汀

Report date: 2026/05/26 20:00:28
NME

Base Information

Drug NameAgomelatine
Drug Alias NameVestinAlodilagomelatinumMelitoragomelatina +[13] 
ClassificationSmall molecules
Mechanisms of ActionMelatonin receptor 1A agonistsSerotonin 2c (5-HT2c) receptor antagonistsMelatonin receptor 1B agonists
TargetsMelatonin receptor 1AMelatonin receptor 1BSerotonin 2c (5-HT2c) receptor
Therapy Area/IndicationsDepressive Disorder, MajorObsessive-Compulsive DisorderAnxiety +[5] 
Global Approved IndicationsDepressive Disorder, Major
Approved Indications in ChinaDepressive Disorder, Major
Original Approved Country/TerritoryEU
Original Approved Date2009/02/19
Country/TerritoryUnited StatesSingaporeTaiwan +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLes Laboratoires Servier IndustrieLes Laboratoires Servier
Inactive CompaniesInstitut De Recherches Internationales ServierNovartis Pharma AgServier (Tianjin) Pharmaceutical Co Ltd
Active IndicationsDepressive Disorder, Major
Inactive IndicationsObsessive-Compulsive DisorderAnxietyRenal Insufficiency +[4] 

Other Information

ATC CodeN06AX22
Related LinksWikipediaDrugBankKEGG